Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
137 studies found for:    "Panuveitis"
Show Display Options
Rank Status Study
1 Not yet recruiting Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical Practice
Condition: Active Non-infectious Intermediate, Posterior and Panuveitis
Intervention:
2 Withdrawn Study of FTY720 in Patients With Uveitis
Condition: Acute Noninfectious Posterior, Intermediate, or Pan Uveitis
Interventions: Drug: FTY720;   Drug: Oral Corticosteroid
3 Completed Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis
Conditions: Uveitis;   Panuveitis
Intervention: Drug: Difluprednate Ophthalmic Emulsion
4 Recruiting Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,
Conditions: Non-infectious Intermediate Uveitis;   Non-infectious Posterior Uveitis;   Non-infectious Panuveitis
Interventions: Drug: LFG316;   Drug: Conventional Therapy
5 Completed A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate;   Panuveitis
Interventions: Drug: Placebo;   Drug: LX211
6 Completed A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate;   Panuveitis
Interventions: Drug: Placebo;   Drug: LX211
7 Completed Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
Conditions: Anterior Uveitis;   Panuveitis
Intervention: Drug: Difluprednate Ophthalmic Emulsion
8 Recruiting HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Condition: Uveitis
Intervention:
9 Active, not recruiting A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
Condition: Uveitis
Intervention: Drug: adalimumab
10 Active, not recruiting Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or Panuveitis
Condition: Uveitis Affecting the Posterior Segment
Intervention: Drug: Fluocinolone Acetonide
11 Completed Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis
Conditions: Uveitis;   Posterior Uveitis;   Panuveitis
Intervention: Drug: AEB071
12 Completed A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis
Conditions: Uveitis, Anterior;   Panuveitis
Interventions: Drug: Placebo;   Drug: LX211
13 Recruiting Ocular Sarcoidosis Open Label Trial of ACTHAR Gel
Conditions: Ocular Sarcoidosis;   Panuveitis;   Anterior Uveitis
Interventions: Drug: Repository Corticotropin Injection;   Drug: Repository Corticotropin Injection -Treatment Extension
14 Active, not recruiting A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Conditions: Posterior Uveitis;   Intermediate Uveitis;   Panuveitis
Intervention: Drug: FAI insert
15 Active, not recruiting Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Posterior Uveitis
Conditions: Posterior Uveitis;   Intermediate Uveitis;   Panuveitis
Interventions: Drug: Sham Injection;   Drug: FAI Insert
16 Active, not recruiting Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
Conditions: Posterior Uveitis;   Intermediate Uveitis;   Panuveitis
Interventions: Drug: FAI insert;   Drug: Sham injection
17 Active, not recruiting Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study
Conditions: Intermediate Uveitis;   Posterior Uveitis;   Pan-uveitis
Intervention: Drug: Tocilizumab
18 Recruiting Intravitreal Sirolimus as Therapeutic Approach to Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis
Interventions: Drug: Intravitreal injection 440mcg;   Drug: Intravitreal injection of sirolimus 880mcg
19 Unknown  Sirolimus as Therapeutic Approach to Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis
Intervention: Drug: Sirolimus (rapamycin)
20 Completed Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
Condition: Anterior Uveitis
Intervention: Drug: Difluprednate Ophthalmic Emulsion

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.